Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 2051

1.

Increasing the bactofection capacity of a mammalian expression vector by removal of the f1 ori.

Johnson SA, Ormsby MJ, McIntosh A, Tait SWG, Blyth K, Wall DM.

Cancer Gene Ther. 2018 Aug 13. doi: 10.1038/s41417-018-0039-9. [Epub ahead of print]

PMID:
30100607
2.

Inhibition of microRNA-384-5p alleviates osteoarthritis through its effects on inhibiting apoptosis of cartilage cells via the NF-κB signaling pathway by targeting SOX9.

Zhang W, Cheng P, Hu W, Yin W, Guo F, Chen A, Huang H.

Cancer Gene Ther. 2018 Jul 30. doi: 10.1038/s41417-018-0029-y. [Epub ahead of print]

PMID:
30057417
3.

Quantification and functional evaluation of CD40L production from the adenovirus vector ONCOS-401.

Kuryk L, Møller AW, Jaderberg M.

Cancer Gene Ther. 2018 Jul 30. doi: 10.1038/s41417-018-0038-x. [Epub ahead of print]

PMID:
30057416
4.

Efficient tumor transduction and antitumor efficacy in experimental human osteosarcoma using retroviral replicating vectors.

Kubo S, Takagi-Kimura M, Kasahara N.

Cancer Gene Ther. 2018 Jul 25. doi: 10.1038/s41417-018-0037-y. [Epub ahead of print]

PMID:
30042500
5.

Therapeutic potential of adenovirus-mediated TFF2-CTP-Flag peptide for treatment of colorectal cancer.

Dubeykovskaya ZA, Duddempudi PK, Deng H, Valenti G, Cuti KL, Nagar K, Tailor Y, Guha C, Kitajewski J, Wang TC.

Cancer Gene Ther. 2018 Jul 25. doi: 10.1038/s41417-018-0036-z. [Epub ahead of print]

PMID:
30042499
6.

miR-140-5p inhibits the proliferation and enhances the efficacy of doxorubicin to breast cancer stem cells by targeting Wnt1.

Wu D, Zhang J, Lu Y, Bo S, Li L, Wang L, Zhang Q, Mao J.

Cancer Gene Ther. 2018 Jul 22. doi: 10.1038/s41417-018-0035-0. [Epub ahead of print]

PMID:
30032164
7.

Serum exosomes contain ECRG4 mRNA that suppresses tumor growth via inhibition of genes involved in inflammation, cell proliferation, and angiogenesis.

Mao L, Li X, Gong S, Yuan H, Jiang Y, Huang W, Sun X, Dang X.

Cancer Gene Ther. 2018 Jul 9. doi: 10.1038/s41417-018-0032-3. [Epub ahead of print]

PMID:
29983418
8.

Complex consisting of antisense DNA and β-glucan promotes internalization into cell through Dectin-1 and hybridizes with target mRNA in cytosol.

Fujiwara N, Izumi H, Morimoto Y, Sakurai K, Mochizuki S.

Cancer Gene Ther. 2018 Jul 4. doi: 10.1038/s41417-018-0033-2. [Epub ahead of print]

PMID:
29970897
9.

Inducible Caspase9-mediated suicide gene for MSC-based cancer gene therapy.

Rossignoli F, Grisendi G, Spano C, Golinelli G, Recchia A, Rovesti G, Orsi G, Veronesi E, Horwitz EM, Dominici M.

Cancer Gene Ther. 2018 Jun 29. doi: 10.1038/s41417-018-0034-1. [Epub ahead of print]

PMID:
29955091
10.

Cytotoxic response of 5-fluorouracil-resistant cells to gene- and cell-directed enzyme/prodrug treatment.

Durinikova E, Plava J, Tyciakova S, Skvara P, Vojs Stanova A, Kozovska Z, Kucerova L, Matuskova M.

Cancer Gene Ther. 2018 Jun 21. doi: 10.1038/s41417-018-0030-5. [Epub ahead of print]

PMID:
29925898
11.

miR-182 regulates trastuzumab resistance by targeting MET in breast cancer cells.

Yue D, Qin X.

Cancer Gene Ther. 2018 Jun 21. doi: 10.1038/s41417-018-0031-4. [Epub ahead of print]

PMID:
29925897
12.

Upregulation of microRNA-3129 suppresses epithelial ovarian cancer through CD44.

Sun X, Cui M, Tong L, Zhang A, Wang K.

Cancer Gene Ther. 2018 Jun 19. doi: 10.1038/s41417-018-0026-1. [Epub ahead of print]

PMID:
29915283
13.

Enhanced expressions of FHL2 and iASPP predict poor prognosis in acute myeloid leukemia.

Cheng Z, Dai Y, Pang Y, Jiao Y, Zhao H, Zhang Z, Qin T, Hu N, Zhang Y, Ke X, Chen Y, Wu D, Shi J, Fu L.

Cancer Gene Ther. 2018 Jun 18. doi: 10.1038/s41417-018-0027-0. [Epub ahead of print]

PMID:
29910468
14.

Mutational spectrum and prognostic stratification of intermediate-risk acute myeloid leukemia.

Wu S, Dai Y, Zhang Y, Wang X, Wang L, Ma D, Zhang L, Pang Y, Jiao Y, Niu M, Xu K, Ke X, Shi J, Cheng Z, Fu L.

Cancer Gene Ther. 2018 Jun 15. doi: 10.1038/s41417-018-0028-z. [Epub ahead of print]

PMID:
29904089
15.

Inhibitor of growth 3 induces cell death by regulating cell proliferation, apoptosis and cell cycle arrest by blocking the PI3K/AKT pathway.

Zhao S, Wang L, Zhang C, Deng Y, Zhao B, Ren Y, Fu Y, Meng X.

Cancer Gene Ther. 2018 Jun 1. doi: 10.1038/s41417-018-0023-4. [Epub ahead of print]

PMID:
29855536
16.

MicroRNA21 and the various types of myeloid leukemia.

Panagal M, S R SK, P S, M B, M K, Gopinathe V, Sivakumare P, Sekar D.

Cancer Gene Ther. 2018 May 25. doi: 10.1038/s41417-018-0025-2. [Epub ahead of print] Review.

PMID:
29795410
17.

Adenovirus-mediated transfer of HPV 16 E6/E7 antisense RNA combined with cisplatin inhibits cellular growth and induces apoptosis in HPV-positive head and neck cancer cells.

Kojima Y, Otsuki N, Kubo M, Kitamoto J, Takata E, Saito H, Kosaka K, Morishita N, Uehara N, Shirakawa T, Nibu KI.

Cancer Gene Ther. 2018 May 24. doi: 10.1038/s41417-018-0024-3. [Epub ahead of print]

PMID:
29795305
18.

Genomic landscape and prognostic analysis of mantle cell lymphoma.

Yang P, Zhang W, Wang J, Liu Y, An R, Jing H.

Cancer Gene Ther. 2018 May 14. doi: 10.1038/s41417-018-0022-5. [Epub ahead of print]

PMID:
29755111
19.

Endostatin gene therapy delivered by attenuated Salmonella typhimurium in murine tumor models.

Liang K, Liu Q, Li P, Han Y, Bian X, Tang Y, Kong Q.

Cancer Gene Ther. 2018 May 14. doi: 10.1038/s41417-018-0021-6. [Epub ahead of print]

PMID:
29755110
20.

Regulated intratumoral expression of IL-12 using a RheoSwitch Therapeutic System® (RTS®) gene switch as gene therapy for the treatment of glioma.

Barrett JA, Cai H, Miao J, Khare PD, Gonzalez P, Dalsing-Hernandez J, Sharma G, Chan T, Cooper LJN, Lebel F.

Cancer Gene Ther. 2018 May 14. doi: 10.1038/s41417-018-0019-0. [Epub ahead of print]

Supplemental Content

Loading ...
Support Center